HISTAMINE PHOSPHATE

HISTAMINE PHOSPHATE was reported 93 times

HISTAMINE PHOSPHATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FALSE NEGATIVE INVESTIGATION RESULT 60 0.0853
1 ADMINISTRATION SITE ULCER 1 0.0417
2 SKIN TEST POSITIVE 4 0.0043
3 ADMINISTRATION SITE BRUISE 1 0.0029
4 SKIN WOUND 4 0.0024
5 INJECTION SITE ULCER 2 0.0021
6 LOCAL REACTION 1 0.0013
7 MAST CELL ACTIVATION SYNDROME 1 0.0007
8 INJECTION SITE SCAR 1 0.0004
9 TENDERNESS 2 0.0002
10 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
11 FOREIGN BODY SENSATION IN EYES 1 0.0002
12 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
13 ANAPHYLACTIC REACTION 7 0.0001
14 NASAL DISCOMFORT 1 0.0001
15 OCULAR DISCOMFORT 1 0.0001
16 APPLICATION SITE RASH 1 0.0001
17 SKIN HAEMORRHAGE 1 0.0001
18 ULCER 1 0.0001
19 SCAR 1 0.0001
20 DYSTONIA 1 0.0001
21 SKIN FISSURES 1 0.0001
22 APPLICATION SITE ERYTHEMA 1 0.0000
23 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
24 LACRIMATION INCREASED 1 0.0000
25 DRUG ADMINISTRATION ERROR 1 0.0000
26 HYPOXIA 1 0.0000
27 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
28 DRY EYE 1 0.0000
29 DERMATITIS ATOPIC 1 0.0000
30 TREATMENT NONCOMPLIANCE 1 0.0000
31 EYE PAIN 1 0.0000
32 WHEEZING 1 0.0000
33 SWELLING FACE 1 0.0000
34 INJECTION SITE PRURITUS 1 0.0000
35 ERYTHEMA 3 0.0000
36 AGITATION 1 0.0000
37 HALLUCINATION 1 0.0000
38 DRUG INEFFECTIVE 17 0.0000
39 URTICARIA 2 0.0000
40 SKIN EXFOLIATION 1 0.0000
41 HYPERSENSITIVITY 2 0.0000
42 CONTUSION 1 0.0000
43 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
44 JOINT SWELLING 1 0.0000
45 VISUAL IMPAIRMENT 1 0.0000
46 DRY SKIN 1 0.0000
47 PRODUCT DOSE OMISSION ISSUE 2 0.0000
48 BLOOD PRESSURE INCREASED 1 0.0000
49 INJECTION SITE PAIN 2 0.0000
50 PERIPHERAL SWELLING 1 0.0000
51 MYOCARDIAL INFARCTION 1 0.0000
52 HYPOTENSION 1 0.0000
53 INSOMNIA 1 0.0000
54 FALL 1 0.0000
55 ASTHENIA 1 0.0000
56 RASH 1 0.0000
57 DYSPNOEA 1 0.0000
58 PAIN 1 0.0000